Novo Nordisk
NVO
#28
Rank
โ‚น29.164 T
Marketcap
โ‚น7,009
Share price
2.97%
Change (1 day)
-20.07%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2024 (TTM): โ‚น1.489 Trillion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚น39.69 Billion. In 2023 the company made an earning of โ‚น1.334 Trillion, an increase over its 2022 earnings that were of โ‚น846.67 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚น1.489 T11.57%
2023 โ‚น1.334 T57.64%
2022 โ‚น846.67 B5.35%
2021 โ‚น803.67 B12.47%
2020 โ‚น714.56 B13.07%
2019 โ‚น631.97 B-3.35%
2018 โ‚น653.87 B1.79%
2017 โ‚น642.35 B4.52%
2016 โ‚น614.56 B9.42%
2015 โ‚น561.67 B8.24%
2014 โ‚น518.92 B3.45%
2013 โ‚น501.62 B19.02%
2012 โ‚น421.47 B15.21%
2011 โ‚น365.84 B17.71%
2010 โ‚น310.79 B24.78%
2009 โ‚น249.06 B10.62%
2008 โ‚น225.14 B55.97%
2007 โ‚น144.35 B7.07%
2006 โ‚น134.82 B18.18%
2005 โ‚น114.08 B11.33%
2004 โ‚น102.47 B
2002 โ‚น62.60 B-14.39%
2001 โ‚น73.12 B-52.82%
2000 โ‚น154.98 B250%
1999 โ‚น44.28 B31.21%
1998 โ‚น33.74 B34.31%
1997 โ‚น25.12 B11.46%
1996 โ‚น22.54 B9.03%
1995 โ‚น20.67 B-3.15%
1994 โ‚น21.34 B-0.67%
1993 โ‚น21.49 B45.38%
1992 โ‚น14.78 B-13.81%
1991 โ‚น17.15 B37.12%
1990 โ‚น12.50 B-0.79%
1989 โ‚น12.60 B26.2%
1988 โ‚น9.98 B24.97%
1987 โ‚น7.99 B-0.9%
1986 โ‚น8.06 B-7.78%
1985 โ‚น8.74 B24.87%
1984 โ‚น7.00 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚น600.57 B-61.09%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น878.02 B-43.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น595.13 Billion-138.56%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น640.78 B-58.48%๐Ÿ‡ซ๐Ÿ‡ท France